Immunization via the gastric mucosa - An approach to boost and modulate immunity with DNA vaccine

Central-European Journal of Immunology

Volumn 25, Issue 3, 2000, Pages 130-136

  Lee, S ^a   Chun, S ^a   Seong Kug Eo, ^a   Rouse, B T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

DNA vaccine; Herpes simplex virus (HSV); Mucosal immunization

Indexed keywords

ANTIGEN; DNA VACCINE; GAMMA INTERFERON; GLYCOPROTEIN B; INTERLEUKIN 10; PLASMID DNA; PRIMER DNA; RECOMBINANT VACCINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; STOMACH MUCOSA; VACCINATION; VIRULENCE;

EID: 0034522326     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. DNA vaccines
2. DNA vaccines - A modern gimmick or a boom to vaccinology?
3. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
4. Immune modulation by IL-10 gene transfer via viral vector and plasmid DNA: Implication for gene therapy
5. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model
6. The prime-boost strategy: Exciting prospects for improved vaccination
7. Boosting with recombinant vaccinia increases immunogenecity and protective efficacy of malaria DNA vaccine
8. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 env antibody elicited by DNA priming and protein boosting
9. Enhanced T cell immunogenecity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
10. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex type 2
11. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract
12. Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4 TH1 T cells
13. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization
14. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses
15. Long lasting protective immunity to experimental autoimmune encephalomyelitis following vaccination with naked DNA encoding C-C chemokines
16. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration
17. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp 120 protein subunit
18. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity
19. Distribution fate and mechanism of immune modulation following mucosal delivery of plasmid DNA encoding IL-10
20. Neonatal immuno-responsiveness
21. DNA immunization of neonates induces immunity despite the presence of maternal antibody
22. Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization
23. IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th 1 type CD4 T cell-mediated protective immunity against herpes simplex virus-2 challenge